News & Legal Notices
Posted on April 3, 2023
Recall: Certain Lots of Dabigatran Etexilate Capsules, Due to Potential Presence of N-Nitroso dabigatran Impurity
Posted on April 3, 2023
Medical Injectables Program Updates: May 2023
Posted on April 3, 2023
Medical Policy Revision: Applied Behavior Analysis in the Treatment of Autism Spectrum Disorders (ASD)
Posted on April 3, 2023
Update Your Provider Data with our Data Submission Template
Posted on April 3, 2023
Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirements
Posted on April 2, 2023
Tools and Training for You During National Minority Health Month
Posted on March 27, 2023
Reimbursement Policy Update: Pre-Admission Testing
Posted on March 27, 2023
Administrative Policy Update: Allowable Practice Locations for Pathologists
Posted on March 26, 2023
Thank you doctors, for your dedication
Posted on March 20, 2023